Zhang, Ji-chun

Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets

Zhang, J.-C., Yao, W., & Hashimoto, K. (2016) · Current Neuropharmacology

Tryptophan and brain disordersTreatment of Major Depression

Cited by 538

R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine

Zhang, J.-C., Li, S.-X., & Hashimoto, K. (2014) · Pharmacology Biochemistry and Behavior

Treatment of Major DepressionTryptophan and brain disorders

Cited by 357

Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation

Zhang, J.-C., Wu, J., Fujita, Y., Yao, W., Ren, Q., Yang, C., Li, S.-X., Shirayama, Y., & Hashimoto, K. (2015) · International Journal of Neuropsychopharmacology

Treatment of Major DepressionTryptophan and brain disorders

Cited by 289

Microglial ERK-NRBP1-CREB-BDNF Signaling in Sustained Antidepressant Actions of (R)-Ketamine

Yao, W., Cao, Q., Luo, S., He, L., Yang, C., Chen, J., Qi, Q., Hashimoto, K., & Zhang, J.-C. (2022) · Molecular Psychiatry

Treatment of Major DepressionTryptophan and brain disorders

Cited by 216

Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression

Zhang, J.-C., Yao, W., Dong, C., Yang, C., Ren, Q., Ma, M., Han, M., & Hashimoto, K. (2015) · Psychopharmacology

Treatment of Major DepressionTryptophan and brain disorders

Cited by 183

Targeting of NMDA receptors in the treatment of major depression

Dang, Y.-H., Ma, X.-C., Zhang, J.-C., Ren, Q., Wu, J., Gao, C.-G., & Hashimoto, K. (2014) · Current Pharmaceutical Design

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 79

Keap1-Nrf2 signaling pathway confers resilience versus susceptibility to inescapable electric stress

Zhang, J.-C., Yao, W., Dong, C., Han, M., Shirayama, Y., & Hashimoto, K. (2018) · European Archives of Psychiatry and Clinical Neuroscience

Genomics, phytochemicals, and oxidative stressTreatment of Major Depression

Cited by 66

Suppression of abnormal α-synuclein expression by activation of BDNF transcription ameliorates Parkinson’s disease-like pathology

Cao, Q., Luo, S., Yao, W., Qu, Y., Wang, N., Hong, J., Murayama, S., Zhang, Z., Chen, J., Hashimoto, K., et al. (2022) · Molecular Therapy - Nucleic Acids

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 41